logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9801832 B1

PDFFull Text
Expired
Date of Patent:
Oct. 31, 2017

Filed:

Jun. 20, 2013

Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction

Applicant:

Universitaetsklinikum Freiburg, Freiburg, DE;

Inventor:

Georg Bauer, Freiburg, DE;

Assignee:

Universitaetsklinikum Freiburg, Freiburg, DE;

Attorneys:

Chalin A. Smith

Smith Patent, LLC

Primary Examiner:

Jeffrey S Lundgren

Assistant Examiner:

Michael Schmitt

Int. Cl.
CPC ...
A61K 31/60 (2006.01); A61K 31/352 (2006.01); C07K 16/40 (2006.01); A61K 31/337 (2006.01); A61K 31/105 (2006.01); A61K 31/05 (2006.01); A61K 31/496 (2006.01); A61K 31/4164 (2006.01); A61K 31/26 (2006.01); A61K 31/198 (2006.01); A61K 31/375 (2006.01); A61K 31/519 (2006.01); A61K 31/10 (2006.01); A61K 31/366 (2006.01); A61K 31/4196 (2006.01); A61K 31/426 (2006.01); A61K 31/427 (2006.01); A61K 31/69 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 31/10 (2013.01); A61K 31/105 (2013.01); A61K 31/198 (2013.01); A61K 31/26 (2013.01); A61K 31/337 (2013.01); A61K 31/352 (2013.01); A61K 31/366 (2013.01); A61K 31/375 (2013.01); A61K 31/4164 (2013.01); A61K 31/4196 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/496 (2013.01); A61K 31/519 (2013.01); A61K 31/60 (2013.01); A61K 31/69 (2013.01); C07K 16/40 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract

The present patent application relates to a pharmaceutical composition, characterized in that it comprises at least one active ingredient which can bring about a singlet oxygen-independent direct catalase inactivation and that the composition further comprises at least one active ingredient that leads to inactivation of catalase as a result of modulation of the nitrogen oxide or superoxide anion metabolism of the cells and subsequent singlet oxygen formation.

Find Patent Forward Citations

Bauer, Georg. (2017). Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction (U.S. Patent No. 9801832). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9801832

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…